New survey shows key voter groups break for candidates with mental health solutions
Results align with previous polls showing mental health a top issue among voters Washington, D.C., May 16, 2024 – Two new surveys released today suggest that U.S. political candidates who endorse concrete solutions to major mental health issues will attract support from key voting blocs: suburban women and people directly affected by mental illness. The survey […]
SPRING Summit maps solutions to transform patient journey for people living with schizophrenia
People with the severe brain disease, care partners & healthcare providers collaborate to create new “Roadmap to Recovery” Washington, D.C., May 15, 2024 – More than 125 people with schizophrenia, their families/care partners and other schizophrenia stakeholders are convening here today to discuss the most glaring gaps in care for this severe brain disease and […]
S&PAA Joins Schizophrenia Spectrum Biomarkers Consortium to Support Earlier Diagnosis, Development of New Treatments for Severe Brain Disease
April 5, 2023 – The Schizophrenia & Psychosis Action Alliance has joined the Schizophrenia Spectrum Biomarkers Consortium, organized by the Foundation for the National Institutes of Health to identify certain signs in the body that could help diagnose schizophrenia earlier and guide development of new treatments. Schizophrenia is one of the most disabling medical conditions, […]
New Voice of the Patient Report showcases the urgent need for better schizophrenia treatments
Feb. 7, 2023 – The Schizophrenia & Psychosis Action Alliance and its partners today released the Voice of the Patient Report, which captures the powerful stories of people living with schizophrenia and those who care for them. The report summarizes the compelling testimony provided during the Nov. 2 Externally-Led Patient-Focused Drug Development meeting on schizophrenia, […]
Press Releases
All press releases
New coalition will combat most common barrier to care for people living with schizophrenia
The Schizophrenia & Psychosis Action Alliance (S&PAA) has formed a strategic collaboration with the Henry Amador Center on Anosognosia and the LEAP Institute to create The Anosognosia Coalition, whose goals are to raise insights into and awareness of the destructive condition of anosognosia and create policies to reduce its negative impact on people living with schizophrenia and psychosis disorders.
Landmark Patient-Focused Drug Development Meeting on Schizophrenia Will Spotlight Urgent Need for New, Better Treatments
November 2 event designed to tell drug developers, FDA reviewers what really matters to people living with the brain disease
New Congressional bill will spotlight actual prevalence, cost burden of schizophrenia
The Cost of Mental Illness Act of 2022 authorizes groundbreaking studies to improve system of care for people living with the brain disease
New Board Members Join Our Transformational Movement
Schizophrenia & Psychosis Action Alliance (S&PAA) has launched a bold agenda to lead a system-widemovement for theimprovement of access to medical care, supports and equity for the millions of people living with schizophrenia and psychosis spectrum disorders.
2025 Headlines
All headlines